Skip to main content
Clinical Trials/NCT06386536
NCT06386536UnknownNot Applicable

Cycling for Improved Health: Development and Evaluation of TRIVEL's Smart Bike Training Prescription Programs

Sylvie Nadeau2 sites in 1 country10 target enrollmentStarted: January 15, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
10
Locations
2
Primary Endpoint
Leg strength and endurance

Study Overview

Brief Summary

This pilot A-B study aims to develop and validate personalized training programs for older adults with decreased mobility on a Semi-Reclining Intelligent Stationary Bike prototype.

The study also aims to assess the feasibility and acceptability of the training programs and to document their preliminary effects on physical health, perceived well-being, and quality of life. Ten participants will take part in five personalized training sessions with the intelligent bike and five standard training sessions with a traditional stationary bike.

Detailed Description

An intelligent stationary bike prototype (iBike) is being developed to evaluate the lower limbs' function during pedaling. The iBike uses artificial intelligence to prescribe personalized training programs based on individual pedaling data. This pilot study aims to develop the training programs, validate their prescription by the iBike, and assess their feasibility, acceptability, and preliminary effects on physical health, perceived well-being, and quality of life in older adults with decreased mobility.

First, the iBike training modules will be developed through a thorough literature review, and prescription criteria will be identified based on the users' pedaling and clinical data as well as expert opinion. Second, 10 participants' lower limb function (i.e. strength, range of motion, coordination and endurance) will be evaluated by the iBike during active and passive pedaling. The evaluation results will be used by the iBike to prescribe a personalized training program. Expert clinicians will also be provided with the ibike evaluation data and will be asked to recommend a personalized exercise program for each participant based on their data. The iBike's prescription of training programs will be validated by comparing it with that of expert clinicians. Third, the feasibility, acceptability, and preliminary effects of the iBike training programs on mobility, physical health, perceived well-being, and quality of life will be assessed through ten training sessions (twice weekly for 45 minutes) with ten older adults using an A-B study design. During the A and B phases, participants will undergo training with either the iBike or a conventional stationary bike.

Ultimately, the goal is to deploy and test this technology in various living spaces and rehabilitation environments to demonstrate its benefits on the physical activity level of healthy older adults and those with mobility problems.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
50 Years to 95 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Being aged 50 and over
  • Having impaired standing mobility associated with aging and/or a stable chronic illness (> 6 months; controlled health condition, no change in medication, routine medical follow-up ; no emergency consultation episode).
  • Being able to walk without human assistance for short distances
  • Being able to tolerate 90 minutes of activities with rest.
  • Being able able to come to the research center for 13 visits, twice a week.

Exclusion Criteria

  • Individuals with or at high risk of having a heart or lung condition (thoracic surgery, angina, myocardial infarction, uncontrolled high blood pressure, shortness of breath at rest).
  • Being unable to pedal on a seated stationary bike.
  • Having active treatments, including physiotherapy and occupational therapy.
  • Having moderate and severe cognitive problems (Mini-Mental State Examination (MMSE) score≤ 21/30).

Outcomes

Primary Outcomes

Leg strength and endurance

Time Frame: 8-9 weeks

The sit to stand test: evaluated as the number of stands a person can complete in 30 seconds. This outcome will be measured 3 times at baseline and once at the end of each phase of the trial.

Walking ability and functional capacity

Time Frame: 8 to 10 weeks

2min walk test (2MWT): the participants will be asked to walk as fast as they can, safely, without assistance for two minutes. This outcome will be measured 3 times at baseline and once at the end of each phase of the trial.

Secondary Outcomes

  • Quality of life(8-9 weeks)
  • Well-being(8-9 weeks)

Investigators

Sponsor
Sylvie Nadeau
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Sylvie Nadeau

Professor

Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal

Study Sites (2)

Loading locations...

Similar Trials